(Q34067137)

30 July 2017

1 reference

title

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. (English)

1 reference

30 July 2017

R M Lane

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Journal of Psychopharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

192-214

1 reference

The `subcortical dementia' of progressive supranuclear palsy

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Cognitive function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Akathisia: a review and case report following paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Urinary retention with fluoxetine-haloperidol combination in a young patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Fluoxetine-induced suicidality, serotonin, and seasonality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Extrapyramidal side effects with low-dose risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Persistent dyskinesia in a patient receiving fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Parkinsonism in neuroleptic-naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Fluoxetine and extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Modulation of central cholinergic activity by GABA and serotonin: PET studies with 11C-benztropine in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Tardive dyskinesia associated with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Levodopa-induced dyskinesias are improved by fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Fluoxetine and tics in an adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Drug-drug interactions involving antidepressants: focus on venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Fluoxetine and extrapyramidal symptoms in CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Dystonias and dyskinesias of the jaw associated with the use of SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Propanolol for fluoxetine-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Paroxetine-induced chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Possible development of the serotonin syndrome in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Structure and function of the brain serotonin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

5-HT and motor control: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Treatment of depression in Parkinson's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Behavioral aspects of serotonin-dopamine interaction in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Neuroanatomic substrates of depression in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

The SSRIs: advantages, disadvantages and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Dystonia associated with trazodone and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Possible adverse drug interactions between fluoxetine and other psychotropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Iontophoretic effects of sigma ligands on rubral neurons in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

The relationship of serotonin to depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Serotonergic dysfunction in depression associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Neurobehavioral changes associated with caudate lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Serotonin syndrome produced by a combination of fluoxetine and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Noradrenergic mechanisms in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Sertraline and akathisia: spontaneous resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

MRI and neuropsychological differences in early- and late-life-onset geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Imipramine withdrawal: an akathisia-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Dyskinesias following treatment with 5-HT re-uptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Comparison of cortical and subcortical lesions in the production of poststroke mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Debrisoquine hydroxylation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Increase of Parkinson disability after fluoxetine medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Extrapyramidal symptoms upon discontinuation of fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Phenomenology and Prevalence of Neuroleptic-Induced Akathisia in Late Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Emergence of intense suicidal preoccupation during fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Effects of high dose propranolol treatment on dopamine and norepinephrine metabolism in regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200212

10.1177/026988119801200212

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference